Literature DB >> 33213320

Impact of Traditional Plants and their Secondary Metabolites in the Discovery of COVID-19 Treatment.

Shabana Bibi1, Ayesha Sarfraz2, Ghazala Mustafa3, Zeeshan Ahmad4, Muhammad A Zeb5, Yuan-Bing Wang1, Tahir Khan1, Muhammad S Khan2, Mohammad A Kamal6, Hong Yu1.   

Abstract

BACKGROUND: Coronavirus Disease-2019 belongs to the family of viruses which cause serious pneumonia along with fever, breathing issues and infection of lungs, and was first reported in China and later spread worldwide.
OBJECTIVE: Several studies and clinical trials have been conducted to identify potential drugs and vaccines for Coronavirus Disease-2019. The present study listed natural secondary metabolites identified from plant sources with antiviral properties and could be a safer and tolerable treatment for Coronavirus Disease-2019.
METHODS: A comprehensive search on the reported studies was conducted using different search engines such as Google Scholar, SciFinder, Sciencedirect, Medline PubMed, and Scopus for the collection of research articles based on plant-derived secondary metabolites, herbal extracts, and traditional medicine for coronavirus infections.
RESULTS: Status of COVID-19 worldwide and information of important molecular targets involved in COVID- 19 are described, and through literature search, it is highlighted that numerous plant species and their extracts possess antiviral properties and are studied with respect to coronavirus treatments. Chemical information, plant source, test system type with a mechanism of action for each secondary metabolite are also mentioned in this review paper.
CONCLUSION: The present review has listed plants that have presented antiviral potential in the previous coronavirus pandemics and their secondary metabolites, which could be significant for the development of novel and a safer drug which could prevent and cure coronavirus infection worldwide. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  COVID-19; TCM; coronavirus; dietary supplementation; herbal medicine; plant; secondary metabolites

Year:  2021        PMID: 33213320     DOI: 10.2174/1381612826666201118103416

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

1.  Scientometric assessment of scientific documents published in 2020 on herbal medicines used for COVID-19.

Authors:  Rasha Atlasi; Aboozar Ramezani; Ozra Tabatabaei-Malazy; Sudabeh Alatab; Vahideh Oveissi; Bagher Larijani
Journal:  J Herb Med       Date:  2022-07-11       Impact factor: 2.542

Review 2.  Non-nucleoside structured compounds with antiviral activity-past 10 years (2010-2020).

Authors:  Marta Denel-Bobrowska; Agnieszka B Olejniczak
Journal:  Eur J Med Chem       Date:  2022-01-19       Impact factor: 7.088

Review 3.  Modern drug discovery applications for the identification of novel candidates for COVID-19 infections.

Authors:  Isha Rani; Avjit Kalsi; Gagandeep Kaur; Pankaj Sharma; Sumeet Gupta; Rupesh K Gautam; Hitesh Chopra; Shabana Bibi; Syed Umair Ahmad; Inderbir Singh; Manish Dhawan; Talha Bin Emran
Journal:  Ann Med Surg (Lond)       Date:  2022-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.